EP0544657A4 - Method for making uniformly-sized particles from insoluble compounds - Google Patents

Method for making uniformly-sized particles from insoluble compounds

Info

Publication number
EP0544657A4
EP0544657A4 EP19900912514 EP90912514A EP0544657A4 EP 0544657 A4 EP0544657 A4 EP 0544657A4 EP 19900912514 EP19900912514 EP 19900912514 EP 90912514 A EP90912514 A EP 90912514A EP 0544657 A4 EP0544657 A4 EP 0544657A4
Authority
EP
European Patent Office
Prior art keywords
sized particles
insoluble compounds
making uniformly
uniformly
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900912514
Other versions
EP0544657A1 (en
Inventor
Michael R. Violante
Harry W. Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25675878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0544657(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Rochester filed Critical University of Rochester
Publication of EP0544657A1 publication Critical patent/EP0544657A1/en
Publication of EP0544657A4 publication Critical patent/EP0544657A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0476—Particles, beads, capsules, spheres
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00—Compounds of aluminium
    • C01F7/02—Aluminium oxide; Aluminium hydroxide; Aluminates
    • C01F7/34—Preparation of aluminium hydroxide by precipitation from solutions containing aluminium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
EP19900912514 1984-05-21 1990-08-21 Method for making uniformly-sized particles from insoluble compounds Withdrawn EP0544657A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61272584A 1984-05-21 1984-05-21
CA002089075A CA2089075A1 (en) 1984-05-21 1990-08-21 Method for making uniformly-sized particles from insoluble compounds

Publications (2)

Publication Number Publication Date
EP0544657A1 EP0544657A1 (en) 1993-06-09
EP0544657A4 true EP0544657A4 (en) 1993-08-04

Family

ID=25675878

Family Applications (2)

Application Number Title Priority Date Filing Date
EP85201206A Expired - Lifetime EP0169618B2 (en) 1984-05-21 1985-05-21 Method for making uniformly sized particles from water-insoluble organic compounds
EP19900912514 Withdrawn EP0544657A4 (en) 1984-05-21 1990-08-21 Method for making uniformly-sized particles from insoluble compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP85201206A Expired - Lifetime EP0169618B2 (en) 1984-05-21 1985-05-21 Method for making uniformly sized particles from water-insoluble organic compounds

Country Status (7)

Country Link
EP (2) EP0169618B2 (en)
JP (1) JPH072209B2 (en)
KR (1) KR930701346A (en)
AU (1) AU579166B2 (en)
CA (2) CA1282405C (en)
PT (1) PT80494B (en)
WO (1) WO1992003380A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606939A (en) * 1983-06-22 1986-08-19 The Ohio State University Research Foundation Small particle formation
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4783484A (en) * 1984-10-05 1988-11-08 University Of Rochester Particulate composition and use thereof as antimicrobial agent
NL194638C (en) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol.
DK181988A (en) * 1988-03-30 1989-10-01 Dumex Ltd As THIOCARBAMIC ACID RESIDUES FOR USE AS A THERAPEUTIC AND PREPARATION FOR THE TREATMENT OF ALCOHOL ABUSE
SE464743B (en) * 1989-06-21 1991-06-10 Ytkemiska Inst PROCEDURE FOR PREPARATION OF MEDICINAL PARTICLES
DE3936053A1 (en) * 1989-10-28 1991-05-02 Basf Ag METHOD FOR IMPROVING THE BIODEGRADABILITY OF PHARMACEUTICAL AGENTS WITH PEPTIDE BINDINGS
US6350462B1 (en) * 1990-12-26 2002-02-26 Olympus Optical Co., Ltd. Hollow porous ceramic carrier for embedding in patient for sustained medicament release and method of preparation thereof
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
MX9201782A (en) * 1991-04-19 1992-10-01 Sandoz Ag PARTICLES OF BIOLOGICALLY ACTIVE SUBSTANCES, SUBSTANTIALLY INSOLUBLE IN WATER, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
AU2317592A (en) * 1991-07-05 1993-02-11 University Of Rochester Ultrasmall non-aggregated porous particles entrapping gas-bubbles
DK0644755T3 (en) * 1992-06-10 1997-09-22 Nanosystems Llc Surface Modified NSAID Nanoparticles
DE4329446A1 (en) * 1993-09-01 1995-03-02 Basf Ag Process for the production of finely divided color or active substance preparations
SE9403846D0 (en) * 1994-11-09 1994-11-09 Univ Ohio State Res Found Small particle formation
SE9501384D0 (en) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
ES2212083T3 (en) * 1996-10-03 2004-07-16 Hermes Biosciences, Inc. HYDROPHILE MICROPARTICLES AND PROCEDURE TO PREPARE THEM.
EP1369111A1 (en) * 1996-10-03 2003-12-10 Hermes Biosciences, Inc. Hydrophilic microparticles and methods to prepare same
US5965729A (en) 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
PL197740B1 (en) * 1997-02-05 2008-04-30 Merck & Co Inc Method of crystallising and inhibitor of reverse hiv transcriptase using an antisolvent
SE9701956D0 (en) 1997-05-23 1997-05-23 Astra Ab New composition of matter
DE19856432A1 (en) 1998-12-08 2000-06-15 Basf Ag Nanoparticulate core-shell systems and their use in pharmaceutical and cosmetic preparations
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DK1347747T3 (en) * 2000-12-22 2006-04-10 Baxter Int Process for treating submicroparticle suspensions of pharmaceutical agents
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
CA2461349C (en) 2001-09-26 2011-11-29 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US6864373B2 (en) * 2002-05-13 2005-03-08 Pharmacia Corporation Stable amorphous celecoxib composite and process therefor
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
JP4326197B2 (en) * 2002-08-30 2009-09-02 独立行政法人科学技術振興機構 Novel process for producing pigment nanoparticles
US7511079B2 (en) 2003-03-24 2009-03-31 Baxter International Inc. Methods and apparatuses for the comminution and stabilization of small particles
EA017290B1 (en) 2005-11-28 2012-11-30 Домейн Раша Инвестментс Лимитед Ganaxolone-based formulations
JP2010510988A (en) 2006-11-28 2010-04-08 マリナス ファーマシューティカルズ Nanoparticle formulation, method for producing the same and use thereof
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
CN105147594A (en) * 2007-11-30 2015-12-16 恩德制药解决方案公司 Compositions and methods for the treatment of bladder cancer
CN106068319A (en) * 2014-03-10 2016-11-02 国立大学法人东京大学 Water dispersible noncrystalline particle and preparation method thereof
KR20180082457A (en) 2015-10-16 2018-07-18 마리누스 파마슈티컬스 인코포레이티드 Injectable neuro-steroid agents containing nanoparticles
JP2019524816A (en) 2016-08-11 2019-09-05 オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． Methods and compositions for the treatment of epileptic disorders
US10391105B2 (en) 2016-09-09 2019-08-27 Marinus Pharmaceuticals Inc. Methods of treating certain depressive disorders and delirium tremens
WO2020118142A1 (en) 2018-12-07 2020-06-11 Marinus Pharmaceuticals, Inc. Ganaxolone for use in prophylaxis and treatment of pospartum depression
WO2021026124A1 (en) 2019-08-05 2021-02-11 Marinus Pharmaceuticals, Inc. Ganaxolone for use in treatment of status epilepticus
KR20220134529A (en) 2019-12-06 2022-10-05 마리누스 파마슈티컬스 인코포레이티드 Ganaxolone for use in the treatment of complex tuberous sclerosis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB899667A (en) * 1960-04-19 1962-06-27 Glaxo Lab Ltd Crystalline griseofulvin
EP0147767A2 (en) * 1983-12-30 1985-07-10 Hoechst Aktiengesellschaft Preparations of poorly water soluble anthelmintics, and process for making them
US4997454A (en) * 1984-05-21 1991-03-05 The University Of Rochester Method for making uniformly-sized particles from insoluble compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887692A (en) * 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
DE2348334C2 (en) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim New form of preparation of N-4- [2- (5-chloro-2-methoxybenzamido) ethyl] -phenyl-sulfonyl-N'-cyclohexylurea
US4606939A (en) * 1983-06-22 1986-08-19 The Ohio State University Research Foundation Small particle formation
US4670461A (en) * 1984-04-26 1987-06-02 The United States Of America As Represented By The Department Of Health And Human Services Formaldehyde derivatives of mitindomide
US4783484A (en) * 1984-10-05 1988-11-08 University Of Rochester Particulate composition and use thereof as antimicrobial agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB899667A (en) * 1960-04-19 1962-06-27 Glaxo Lab Ltd Crystalline griseofulvin
EP0147767A2 (en) * 1983-12-30 1985-07-10 Hoechst Aktiengesellschaft Preparations of poorly water soluble anthelmintics, and process for making them
US4997454A (en) * 1984-05-21 1991-03-05 The University Of Rochester Method for making uniformly-sized particles from insoluble compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9203380A1 *

Also Published As

Publication number Publication date
AU4501285A (en) 1987-01-22
KR930701346A (en) 1993-06-11
EP0169618B1 (en) 1990-08-29
EP0169618B2 (en) 1993-11-10
EP0544657A1 (en) 1993-06-09
WO1992003380A1 (en) 1992-03-05
PT80494A (en) 1985-11-22
CA2089075A1 (en) 1992-02-22
PT80494B (en) 1987-08-19
EP0169618A2 (en) 1986-01-29
AU579166B2 (en) 1988-11-17
CA1282405C (en) 1991-04-02
JPS6227032A (en) 1987-02-05
EP0169618A3 (en) 1988-07-27
JPH072209B2 (en) 1995-01-18

Similar Documents

Publication Publication Date Title
EP0544657A4 (en) Method for making uniformly-sized particles from insoluble compounds
US4701267B1 (en) Method for removing leukocytes
EP0152957A3 (en) Method for making ultra-fine ceramic particles
PH16576A (en) Process for reducing phosphate ore
ZA852012B (en) Process for preparing descrete,zeolite-containing particles
EP0176760A3 (en) Process for forming solid solutions
ZA855155B (en) Process for isolating water-soluble acidic compounds
GB2106499B (en) Method for making benzoylphenylureas
GB2119702B (en) Method for the production of particle boards
GB2106500B (en) Method for making benzoylphenylureas
EP0266999A3 (en) A method for the preparation of finely divided metal particles
GB2153856B (en) Method for manufacturing powders
ZA854742B (en) Method for facilitating the flow of fines
HUT38952A (en) Process for 16alpha-metylation
EP0184690A3 (en) Process for the removal of arsenic from phosphino-acid solutions
GB2106501B (en) Method for making benzoylphenylureas
GB2183670B (en) Process for self-hydrogenation
BG47403A1 (en) Method for prepraing of 2, 2, 6, 6- tetramethyl- 4- aminopiperidine
GB8801598D0 (en) Method & apparatus for collecting & conveying objects from surface
HUT37748A (en) Process for preparing leucotriene antagonist compounds
DE3273891D1 (en) Process for making pyridyloxyphenol compounds
DE3173912D1 (en) Method for making thiobiscarbamates
YU44998B (en) Process for obtaining 2-oxindole-1-carboxamide compound
YU43808B (en) Process for obtaining haloalkyl-8-4h(1)-benzopyrane-4-one
IL75250A (en) Method for making uniformly sized particles from water-insoluble organic compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930611

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19940214

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19940625